- Email: [email protected]
WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside
Author’s Accepted Manuscript
WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside Hyun-Jung Kim, Charles L. Edelstein
http://www.krcp-ksn.com
PII: DOI: Reference:
S2211-9132(12)00710-3 http://dx.doi.org/10.1016/j.krcp.2012.07.001 KRCP39
To appear in:
Kidney Research and Clinical Practice
Cite this article as: Hyun-Jung Kim and Charles L. Edelstein, WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside, Kidney Research and Clinical Practice, http://dx.doi.org/ 10.1016/j.krcp.2012.07.001 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside Hyun-Jung Kima,b and Charles L. Edelsteina* a
Division of Renal Diseases and Hypertension, Univ. of Colorado at Denver, Aurora, Colorado, USA b Department of Internal Medicine, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea *
Corresponding author. Tel.: +(3 0 3) 724 4810; fax +(3 0 3) 724 4868. [email protected]
The Publisher regrets that this article is an accidental duplication of an article that has already been published, doi: 10.1016/j.krcp.2012.07.002. The duplicate article has therefore been withdrawn.
WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside Hyun-Jung Kim, Charles L. Edelstein
http://www.krcp-ksn.com
PII: DOI: Reference:
S2211-9132(12)00710-3 http://dx.doi.org/10.1016/j.krcp.2012.07.001 KRCP39
To appear in:
Kidney Research and Clinical Practice
Cite this article as: Hyun-Jung Kim and Charles L. Edelstein, WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside, Kidney Research and Clinical Practice, http://dx.doi.org/ 10.1016/j.krcp.2012.07.001 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
WITHDRAWN: Mammalian target of rapamycin (mTOR) inhibition in polycystic kidney disease (PKD): From bench to bedside Hyun-Jung Kima,b and Charles L. Edelsteina* a
Division of Renal Diseases and Hypertension, Univ. of Colorado at Denver, Aurora, Colorado, USA b Department of Internal Medicine, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea *
Corresponding author. Tel.: +(3 0 3) 724 4810; fax +(3 0 3) 724 4868. [email protected]
The Publisher regrets that this article is an accidental duplication of an article that has already been published, doi: 10.1016/j.krcp.2012.07.002. The duplicate article has therefore been withdrawn.